Lilly adds $375M to Zymeworks partnership

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00
rop-lilly09-2col.jpg

Eli Lilly and Co. and Zymeworks said Wednesday that they are expanding a cancer drug development partnership.

The companies announced a partnership in January but did not disclose terms. Without explaining the initial terms of the partnership, the companies said Zymeworks could get an additional $375 million in milestones and other payments. It will also receive royalties on sales of any approved drugs, and Lilly will make an investment in Zymeworks.

The companies say they will study "bi-specific antibodies," or drugs that use the immune system to treat diseases by targeting two different proteins.

Shares in Indianapolis-based Lilly were unchanged at $64.68 on Wednesday.

Zymeworks is a privately held Canadian company.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In